Why should pharma invest in digital products for those living with rare diseases?
pharmaphorum
NOVEMBER 23, 2022
Consultations and clinical trials are often few and far between. Research in rare diseases will benefit from identifying cause and effect, which consider behaviours, social economics, and the patient’s emotional state. More frequent data points are needed to get the whole picture on rare diseases.
111 
Let's personalize your content